Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Jun 2, 2022
Filed with the SEC on Jun 2, 2022 and accepted by EDGAR at Jun 2, 2022, 07:36 ET.
Items reported
- Item 1.01 Entry into a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-22-067375. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.